Organon & Co. (OGN)

USD 11.3

(1.07%)

Total Debt Summary of Organon & Co.

  • Organon & Co.'s latest annual total debt in 2023 was 8.76 Billion USD , down -1.72% from previous year.
  • Organon & Co.'s latest quarterly total debt in 2024 Q2 was 8.65 Billion USD , down -0.67% from previous quarter.
  • Organon & Co. reported annual total debt of 8.91 Billion USD in 2022, down -2.42% from previous year.
  • Organon & Co. reported annual total debt of 9.13 Billion USD in 2021, up 29364.52% from previous year.
  • Organon & Co. reported quarterly total debt of 8.74 Million USD for 2024 Q3, up 1.07% from previous quarter.
  • Organon & Co. reported quarterly total debt of 8.65 Billion USD for 2024 Q2, down -0.67% from previous quarter.

Annual Total Debt Chart of Organon & Co. (2023 - 2018)

Historical Annual Total Debt of Organon & Co. (2023 - 2018)

Year Total Debt Total Debt Growth
2023 8.76 Billion USD -1.72%
2022 8.91 Billion USD -2.42%
2021 9.13 Billion USD 29364.52%
2020 31 Million USD -70.19%
2019 104 Million USD -30.2%
2018 149 Million USD 0.0%

Peer Total Debt Comparison of Organon & Co.

Name Total Debt Total Debt Difference
AbbVie Inc. 59.38 Billion USD 85.249%
Bristol-Myers Squibb Company 41.46 Billion USD 78.873%
Bristol-Myers Squibb Company Ce 41.46 Billion USD 78.873%
Johnson & Johnson 29.33 Billion USD 70.135%
Eli Lilly and Company 25.22 Billion USD 65.273%
Merck & Co., Inc. 36.26 Billion USD 75.846%
Novartis AG 26.34 Billion USD 66.753%
Pfizer Inc. 75.04 Billion USD 88.326%